CNBCFDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option8 days agoBy Annika Kim ConstantinoMore
Fierce PharmaUptake of Gilead's Yeztugo will be swift, analyst says after discussion with HIV docYesterdayBy Kevin DunleavyMore
The New York TimesRegulators Approve a Twice-Yearly Shot to Prevent H.I.V. Infection8 days agoBy Apoorva MandavilliMore
The Salt Lake TribuneA University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it.YesterdayBy Brock MarchantMore
NBC NewsFDA approves powerful HIV prevention drug: What to know about Yeztugo8 days agoBy Benjamin RyanMore
HealthlineHIV: FDA Approves Highly Effective, Twice-Yearly Shot for Prevention2 days agoBy Andrea RiceMore
AP NewsThe world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it8 days agoBy Lauran NeergaardMore
STATThe decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir3 days agoBy Dr William PaoMore
Harvard Medical School2025 Warren Alpert Prize Honors Scientists Whose Discoveries Culminated in Novel HIV Treatment7 days agoMore
NPRHIV prevention drug hailed as a 'breakthrough' gets FDA approval : Goats and Soda8 days agoBy Jonathan LambertMore
amfAR, The Foundation for AIDS ResearchFDA Approves Lenacapavir for HIV Pre-Exposure Prophylaxis5 hours agoMore
San Francisco ExaminerCoverage questions mute enthusiasm for HIV drug approvalYesterdayBy Natalia Gurevich & Kevin N HumeMore
World Health Organization (WHO)FDA approval of injectable lenacapavir marks progress for HIV prevention7 days agoMore
AJMCCost Will Be Massive Barrier in Access to Lenacapavir After Approval in the US: Gordon Crofoot, MD, PA6 days agoBy Julia BonavitacolaMore
The Washington PostHere’s what everyone should know about this new HIV prevention shot5 days agoBy Teddy Amenabar & Richard SimaMore
Contemporary PediatricsWeekly review: New PrEP for HIV, new HAE treatment, and more3 days agoBy Joshua FitchMore
lovebscottAccess Granted: Mistr Users Now Have Access to Lenacapavir8 hours agoBy Jasmine FranklinMore
Managed Healthcare ExecutiveWith Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert7 days agoBy Logan Lutton & Peter WehrweinMore
The People's PharmacyStopping HIV BEFORE It Starts: Yeztugo Offers Powerful Protection!1 hour agoBy Joe GraedonMore
ABC News - Breaking News, Latest News and VideosVideo FDA approves twice-yearly shot to prevent HIV7 days agoMore
kare11.comAliveness Project to offer newly approved, first-of-its-kind HIV prevention treatment3 days agoBy Samantha FischerMore
KSL NewsFDA approves HIV drug based on University of Utah biochemist's findings3 days agoBy Logan StefanichMore
Regulatory Affairs Professionals Society | RAPSRecon: FDA approves Gilead’s twice-yearly HIV shot; Two top FDA cell and gene therapy leaders pushed out7 days agoMore
WDAM-TVFDA approves twice-yearly injectable for HIV prevention; local agency weighs in on impact in the Pine Belt6 days agoBy Jay HarrisonMore
The Guardian‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers9 days agoBy Kat LayMore
ReutersUS FDA approves Gilead's twice-yearly injection for HIV prevention8 days agoBy Deena Beasley & Julie SteenhuysenMore
the-independent.comGroundbreaking twice-a-year HIV drug that could stop transmission approved7 days agoBy Lauran NeergaardMore
Business WireYeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection8 days agoMore
Discover MagazineFDA Approves Breakthrough HIV Drug, but It Could Be Hard to Access7 days agoBy Monica CullMore
STATHIV protection with just two shots a year: FDA approves Gilead drug8 days agoBy Ed Silverman & Jason MastMore
CBS NewsHIV prevention drug lenacapavir approved by FDA as twice-yearly injection8 days agoBy Sara MoniuszkoMore